{"disease":{"id":"pulmonary-vascular-disorder","name":"pulmonary vascular disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04506528","title":"COVID EHR COHORT at the University of Wisconsin","phase":"","overall_status":"COMPLETED","enrollment_count":1634381,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT07363980","title":"Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Ellen Margrethe Hauge","has_results":false},{"nct_id":"NCT03721952","title":"Facilitating Communication Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":977,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT03184727","title":"Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT02789800","title":"Patient-Centred Innovations for Persons With Multimorbidity - Quebec","phase":"NA","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT02742597","title":"Patient-Centred Innovations for Persons With Multimorbidity - Ontario","phase":"NA","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","has_results":false},{"nct_id":"NCT06053580","title":"Repurposing Valsartan May Protect Against Pulmonary Hypertension","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT06384534","title":"Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT05339087","title":"Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Heidelberg University","has_results":true},{"nct_id":"NCT06084559","title":"HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"University of Zurich","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}